GREAT POINT PARTNERS LLC 13D and 13G filings for Context Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 4:33 pm Sale |
2024-12-31 | 13G | Context Therapeutics Inc. CNTX |
GREAT POINT PARTNERS LLC | 4,683,711 6.250% |
-2,251,271![]() (-32.46%) |
Filing |
2024-11-14 4:52 pm Sale |
2024-09-30 | 13G | Context Therapeutics Inc. CNTX |
GREAT POINT PARTNERS LLC | 6,934,982 9.250% |
-484,373![]() (-6.53%) |
Filing |
2024-06-05 10:45 am Purchase |
2024-05-31 | 13G | Context Therapeutics Inc. CNTX |
GREAT POINT PARTNERS LLC | 7,419,355 9.890% |
7,419,355![]() (New Position) |
Filing |